RIYADH - ImmunityBio, Inc. (NYSE:IBRX) held regulatory discussions with the Saudi Food and Drug Authority (SFDA) that advanced two key priorities for the company’s products in the Kingdom of Saudi ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. We know that the Department of Justice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results